Around 20% of breast cancers produce unusually high levels of a protein known as human epidermal growth factor receptor 2 (HER2), reports the Mayo Clinic.
In the future, DNA assembled into nanostructures—for example, tubes and origami-inspired shapes—could be used in applications ranging from DNA computers to nanomedicine.
Surface engineering of nanocarriers dedicates significant contribution to the area of biomedicine, ranging from drug delivery to theranostic.
Earlier in 2016, the Faculty of Science and Technology at Aarhus University and Novo Nordisk entered into a strategic collaboration contract known as the ‘Aarhus Novo Nordisk Science and Talent Network.’
Nanozymes are catalytic nanomaterials with enzyme-like properties and with the benefits of high stability, low cost, ease of mass production, and tunable catalytic activity.
Bacteria present in the earth have nanometer-sized factories that perform several different things.
New research demonstrates that it is possible to program nanostructures made of DNA molecules to operate as pH-responsive cargo carriers, opening the door toward functional drug-delivery vehicles.
2Ctech, Inc., a privately owned development stage company concerned with the application of nanoparticle technologies for the treatment of retinal diseases, announced the launch of the first-ever clinical program to show the effectiveness and safety of Quantum Dots (QDs) to realize photovoltaic stimulation of the neural retina for preserving or improving vision in patients with retinal degenerative diseases and, specifically, Retinitis Pigmentosa (RP).
Imagine physicians having a remote control that they could employ to drive a patient’s own cells to a wound to accelerate the healing process.
In a to-be-published paper in the upcoming issue in NANO, scientists from Zhejiang have revealed a new method of using nanocarrier-based biological fluorescent probes for identifying ketamine and amphetamine in hidden fingermark, in an attempt to fight drug abuse.